AMGN Filing
144/AFiling Date: Aug 6, 2026

AMGEN INC (AMGN) · Proposed Sale (Form 144/A) SEC Filing

Insider Proposed Sale Notice

descriptionView SEC Filing
ACC: 0001974078-26-000298open_in_new

Sale Plan

Grygiel Nancy A.
Officer·AMGEN INC (AMGN)
Proposed
CommonNASDAQ
Shares2.97K
Est. DateAug 6
Market Value$1.19M
BrokerRaymond James & Associates
AcquisitionCashless Stock Option Exercise · Amgen Inc
Acquired DateApr 27, 2018
Amount Acquired1.97K
% Outstanding0.0006%
Exercise / Payment Details
Paid: Aug 6, 2026Method: Cash
No sales in the past 3 months
Signature & Compliance expand_more
Notice DateAug 6, 2026
Signature Rashida Mitchell, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Nancy A Grygiel
Issuer Info expand_more
CompanyAMGEN INC
CIK0000318154
SEC File No.001-37702
Phone(805)447-1000
AddressONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA 91320

keid analysis is for reference only and does not constitute investment advice.